Cancer

Keyphrases

Publications

volume 130, number 9, 2024

Surabhi Ranjan, Denise Leung, Ashley P Ghiaseddin, Jennie W Taylor, Mina Lobbous, Andrew Dhawan, Joshua A Budhu, Elizabeth Coffee, Kaitlyn Melnick, Sajeel A Chowdhary, Christine Lu-Emerson, Sylvia C Kurz, Joy E Burke, Keng Lam, Mallika P Patel, Erin M Dunbar, Nimish A Mohile, Katherine B Peters
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients. Cancer 130 (9) (2024)
Michael A O'Rorke, Elizabeth A Chrischilles, null null
Making progress against rare cancers: A case study on neuroendocrine tumors. Cancer 130 (9) (2024)
Arti Patel Varanasi, Linda Burhansstipanov, Carrie Dorn, Sharon Gentry, Michele A Capossela, Kyandra Fox, Donna Wilson, Sora Tanjasiri, Olayinka Odumosu, Elba L Saavedra Ferrer
Patient navigation job roles by levels of experience: Workforce Development Task Group, National Navigation Roundtable. Cancer 130 (9) (2024)
Olivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, Rozemarijn S van Rijn, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Jan Willem W B de Groot, Geke A P Hospers, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Marion Stevense-den Boer, Rik J Verheijden, Astrid A M van der Veldt, Michel W J M Wouters, Willeke A M Blokx, Karlijn P M Suijkerbuijk
BRAF/MEK inhibitor rechallenge in advanced melanoma patients. Cancer 130 (9) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Tanya Barauskas Dorff, Alan H Bryce
Challenges in clinical trials for high-risk but curable prostate cancer. Cancer 130 (9) (2024)
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F Easton, Paul D P Pharoah, Nora Pashayan
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer 130 (9) (2024)
Joohyun Hong, Jiyun Lee, Sehhoon Park, Hyun-Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Dong Hyun Sinn, Myung-Ju Ahn
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B. Cancer 130 (9) (2024)
Rana R McKay, Wanling Xie, Xiaoyu Yang, Andres Acosta, Dana Rathkopf, Vincent P Laudone, Glenn J Bubley, David J Einstein, Peter Chang, Andrew A Wagner, Christopher J Kane, Mark A Preston, Kerry Kilbridge, Steven L Chang, Atish D Choudhury, Mark M Pomerantz, Quoc-Dien Trinh, Adam S Kibel, Mary-Ellen Taplin
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial. Cancer 130 (9) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Surabhi Ranjan, Denise Leung, Ashley P Ghiaseddin, Jennie W Taylor, Mina Lobbous, Andrew Dhawan, Joshua A Budhu, Elizabeth Coffee, Kaitlyn Melnick, Sajeel A Chowdhary, Christine Lu-Emerson, Sylvia C Kurz, Joy E Burke, Keng Lam, Mallika P Patel, Erin M Dunbar, Nimish A Mohile, Katherine B Peters
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients. Cancer 130 (9) (2024)
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F Easton, Paul D P Pharoah, Nora Pashayan
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer 130 (9) (2024)
Arti Patel Varanasi, Linda Burhansstipanov, Carrie Dorn, Sharon Gentry, Michele A Capossela, Kyandra Fox, Donna Wilson, Sora Tanjasiri, Olayinka Odumosu, Elba L Saavedra Ferrer
Patient navigation job roles by levels of experience: Workforce Development Task Group, National Navigation Roundtable. Cancer 130 (9) (2024)
Joohyun Hong, Jiyun Lee, Sehhoon Park, Hyun-Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Dong Hyun Sinn, Myung-Ju Ahn
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B. Cancer 130 (9) (2024)
Rana R McKay, Wanling Xie, Xiaoyu Yang, Andres Acosta, Dana Rathkopf, Vincent P Laudone, Glenn J Bubley, David J Einstein, Peter Chang, Andrew A Wagner, Christopher J Kane, Mark A Preston, Kerry Kilbridge, Steven L Chang, Atish D Choudhury, Mark M Pomerantz, Quoc-Dien Trinh, Adam S Kibel, Mary-Ellen Taplin
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial. Cancer 130 (9) (2024)
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F Easton, Paul D P Pharoah, Nora Pashayan
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer 130 (9) (2024)
Stacy Loeb, Qi Hua, Scott R Bauer, Stacey A Kenfield, Alicia K Morgans, June M Chan, Erin L Van Blarigan, Alaina H Shreves, Lorelei A Mucci
Plant-based diet associated with better quality of life in prostate cancer survivors. Cancer 130 (9) (2024)
Josef Rüschoff, Wolfgang Dietmaier, Tina Bocker Edmonston, Reinhard Büttner
Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy. Cancer 130 (9) (2024)
Olivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, Rozemarijn S van Rijn, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Jan Willem W B de Groot, Geke A P Hospers, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Marion Stevense-den Boer, Rik J Verheijden, Astrid A M van der Veldt, Michel W J M Wouters, Willeke A M Blokx, Karlijn P M Suijkerbuijk
BRAF/MEK inhibitor rechallenge in advanced melanoma patients. Cancer 130 (9) (2024)
Michael A O'Rorke, Elizabeth A Chrischilles, null null
Making progress against rare cancers: A case study on neuroendocrine tumors. Cancer 130 (9) (2024)
Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, Adrian A Suarez, Wei Chen, Jessica Gillespie, Alyssa Villacres, Alexis Chassen, David E Cohn, Paul J Goodfellow, Casey M Cosgrove
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy". Cancer 130 (9) (2024)
Stacy Loeb, Qi Hua, Scott R Bauer, Stacey A Kenfield, Alicia K Morgans, June M Chan, Erin L Van Blarigan, Alaina H Shreves, Lorelei A Mucci
Plant-based diet associated with better quality of life in prostate cancer survivors. Cancer 130 (9) (2024)
Tanya Barauskas Dorff, Alan H Bryce
Challenges in clinical trials for high-risk but curable prostate cancer. Cancer 130 (9) (2024)
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, Mitul Shah, Lorenzo Ficorella, Emily Steggall, Douglas F Easton, Paul D P Pharoah, Nora Pashayan
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer 130 (9) (2024)
Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, Adrian A Suarez, Wei Chen, Jessica Gillespie, Alyssa Villacres, Alexis Chassen, David E Cohn, Paul J Goodfellow, Casey M Cosgrove
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy". Cancer 130 (9) (2024)

volume 130, number S17, 2024

Chunwei Xu, Zhanhong Chen, Yuanli Xia, Yanxia Shi, Peifen Fu, Yi-Ding Chen, Xian Wang, Lili Zhang, Hengyu Li, Wenyan Chen, Jianfei Fu, Liming Huang, Jingde Shu, Ouchen Wang, Weizhu Wu, Bojian Xie, Ting Wang, Weiping Zhang, Shurong Shen, Qun Li, Ting Luo, Bin Zhang, Yanru Xie, Hongxia Wang, Qian Wang, Wen-Xian Wang, Ziming Li, Zhengbo Song, Wenfeng Fang, Wen-Zhao Zhong, Yongchang Zhang, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Feng Wang, Rui Meng, Youcai Zhu, Lin Wang, Bing Wan, Dong Wang, Yue Hao, Jianya Zhou, Long Huang, Zhang Zhang, Donglai Lv, Meiyu Fang, Yuanzhi Lu, Lu Si, Yong Song, Xiaojia Wang
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China. Cancer 130 (S17) (2024)

volume 130, number S8, 2024

Jie Wang, Ye-Chen Xia, Bao-Xing Tian, Ju-Tang Li, Heng-Yu Li, Hui Dong, Xiao-Guang Li, Hua Yu, Yu-Yao Zhu, Jun Ma, Ying-Jie Jiang, Guang-Zhi Jin
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer 130 (S8) (2024)
Xiaofen Li, Shiping Luo, Wenfen Fu, Mingyao Huang, Xiewei Huang, Shaohong Kang, Jie Zhang, Qingshui Wang, Chuan-Gui Song
Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer. Cancer 130 (S8) (2024)
Xiaojia Wang, Ruth M O'Regan
Breast cancer therapy in China: Introducing the Special Collection. Cancer 130 (S8) (2024)
Fei Qu, Rongrong Lu, Qian Liu, Xuefang Wu, Xiang Huang, Yongmei Yin, Wei Li
Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer 130 (S8) (2024)
Xupeng Hou, Xueyang Li, Yunwei Han, Hua Xu, Yongjie Xie, Tianxing Zhou, Tongyuan Xue, Xiaolong Qian, Jiazhen Li, Hayson Chenyu Wang, Jingrui Yan, Xiaojing Guo, Ying Liu, Jing Liu
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding. Cancer 130 (S8) (2024)
Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer 130 (S8) (2024)
Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis. Cancer 130 (S8) (2024)
Xupeng Hou, Xueyang Li, Yunwei Han, Hua Xu, Yongjie Xie, Tianxing Zhou, Tongyuan Xue, Xiaolong Qian, Jiazhen Li, Hayson Chenyu Wang, Jingrui Yan, Xiaojing Guo, Ying Liu, Jing Liu
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding. Cancer 130 (S8) (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Qijun Zheng, Huicui Yan, Yingjian He, Jiwei Wang, Nan Zhang, Ling Huo, Yiqiang Liu, Lize Wang, Ling Xu, Zhao-Qing Fan
An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation. Cancer 130 (S8) (2024)
Jie Wang, Ye-Chen Xia, Bao-Xing Tian, Ju-Tang Li, Heng-Yu Li, Hui Dong, Xiao-Guang Li, Hua Yu, Yu-Yao Zhu, Jun Ma, Ying-Jie Jiang, Guang-Zhi Jin
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer 130 (S8) (2024)
Xiaofen Li, Shiping Luo, Wenfen Fu, Mingyao Huang, Xiewei Huang, Shaohong Kang, Jie Zhang, Qingshui Wang, Chuan-Gui Song
Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer. Cancer 130 (S8) (2024)
Weili Xiong, Ting Xu, Xiao Liu, Lili Zhang, Yuan Yuan
Efficacy and safety of nanoparticle albumin-bound paclitaxel in taxane-pretreated metastatic breast cancer patients. Cancer 130 (S8) (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Xingtong Zhou, Mohan Liu, Zhibo Zheng, Xi Cao, Yan Lin, Ying Xu, Yan Li, Hayson Chenyu Wang, Qiang Sun
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Fei Qu, Rongrong Lu, Qian Liu, Xuefang Wu, Xiang Huang, Yongmei Yin, Wei Li
Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer 130 (S8) (2024)
Xingtong Zhou, Mohan Liu, Zhibo Zheng, Xi Cao, Yan Lin, Ying Xu, Yan Li, Hayson Chenyu Wang, Qiang Sun
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study. Cancer 130 (S8) (2024)
Xiaojia Wang, Ruth M O'Regan
Breast cancer therapy in China: Introducing the Special Collection. Cancer 130 (S8) (2024)
Qijun Zheng, Huicui Yan, Yingjian He, Jiwei Wang, Nan Zhang, Ling Huo, Yiqiang Liu, Lize Wang, Ling Xu, Zhao-Qing Fan
An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation. Cancer 130 (S8) (2024)